Skip to content
Open access · CC-BY via OpenAlex

Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer

Soukaina Boutriq, Alicia González-González, Isaac J. Plaza-Andrades, Aurora Laborda-Illanes, Lidia Sánchez‐Alcoholado, Jesús Peralta-Linero, María Emilia Domínguez-Recio, Maria José Bermejo-Pérez, Rocío Lavado-Valenzuela, Emilio Alba, María Isabel Queipo‐Ortuño

Journal of Personalized Medicine · 2021 · ▲ 36 citations

Abstract

Endometrial cancer is one of the most common gynaecological malignancies worldwide. Histologically, two types of endometrial cancer with morphological and molecular differences and also therapeutic implications have been identified. Type I endometrial cancer has an endometrioid morphology and is estrogen-dependent, while Type II appears with non-endometrioid differentiation and follows an estrogen-unrelated pathway. Understanding the molecular biology and genetics of endometrial cancer is crucial for its prognosis and the development of novel therapies for its treatment. However, until now, scant attention has been paid to environmental components like the microbiome. Recently, due to emerging evidence that the uterus is not a sterile cavity, some studies have begun to investigate the composition of the endometrial microbiome and its role in endometrial cancer. In this review, we summarize the current state of this line of investigation, focusing on the relationship between gut and endometrial microbiome and inflammation, estrogen metabolism, and different endometrial cancer therapies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/jpm11070659
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Boutriq, S., González-González, A., Plaza-Andrades, I.J., Laborda-Illanes, A., Sánchez‐Alcoholado, L., Peralta-Linero, J., Domínguez-Recio, M.E., Bermejo-Pérez, M.J., Lavado-Valenzuela, R., Alba, E., &amp; Queipo‐Ortuño, M.I. (2021). Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer. <em>Journal of Personalized Medicine</em>. https://doi.org/10.3390/jpm11070659
Vancouver
Boutriq S, González-González A, Plaza-Andrades IJ, Laborda-Illanes A, Sánchez‐Alcoholado L, Peralta-Linero J, et al. Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer. Journal of Personalized Medicine. 2021. doi:10.3390/jpm11070659.
BibTeX
@article{soukaina2021Gutand, title = {Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer}, author = {Soukaina Boutriq and Alicia González-González and Isaac J. Plaza-Andrades and Aurora Laborda-Illanes and Lidia Sánchez‐Alcoholado and Jesús Peralta-Linero and María Emilia Domínguez-Recio and Maria José Bermejo-Pérez and Rocío Lavado-Valenzuela and Emilio Alba and María Isabel Queipo‐Ortuño}, journal = {Journal of Personalized Medicine}, year = {2021}, doi = {10.3390/jpm11070659}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings